Skip to content

Neurocognitive endophenotyping: on the intersection of genetic disorders and psychiatry

Neurocognitive endophenotyping: on the intersection of genetic disorders and psychiatry - Neurocognitive endophenotyping

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38921
Enrollment
60
Registered
2013-08-15
Start date
2013-12-27
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Disorders Developmental disorders

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Presence of one of the following specific genetic variants - EHMT1 mutation (Kleefstra Syndrome) - KANSL1 mutation (Koolen-deVries syndrome) - ABJRD11 mutation (KBG syndrome) - 15q13 mutation ( Prader-Willi syndrome) - Trisomie 21 (syndroom van Down).;-biological age above 3 years

Exclusion criteria

Exclusion criteria: Multiple genetic defects within one subject

Design outcomes

Primary

MeasureTime frame
neurocognitive profiles

Secondary

MeasureTime frame
-Identification of neurocognitive markers as endophenotypes in different neuropsychiatric diseases caused by EHMT1 defects (ID, schizophrenia and autism). - Identification of cross species neurocognitive markers in EHMT1 defects

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)